Polymyxin B-induced Bartter syndrome.
BMJ Case Rep
; 17(5)2024 May 03.
Article
em En
| MEDLINE
| ID: mdl-38702070
ABSTRACT
Bartter syndrome is a genetic disorder characterised by chloride-unresponsive metabolic alkalosis, hypokalaemia, hypomagnesaemia and hypercalciuria. While it commonly presents antenatally or in early infancy, sometimes, drugs can induce a state similar to Bartter syndrome in any age group, called acquired Bartter syndrome. Polymyxins and aminoglycosides are the most commonly implicated drugs. Polymyxin B and polymyxin E (popularly known as colistin) are the two chemically similar polymyxins that are commonly used clinically. While colistin is frequently associated with nephrotoxicity, polymyxin B is generally considered less nephrotoxic. This difference is due to the way these two drugs are handled by the kidneys. In this case report, we discuss a middle-aged male who developed Bartter syndrome due to polymyxin B, which resolved on discontinuation of the drug, and re-appeared after its re-introduction later. This case exemplifies the nephrotoxicity caused by polymyxin B and the need for vigilance when using this drug.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Polimixina B
/
Síndrome de Bartter
/
Antibacterianos
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article